417716-92-8

Solubility:DMSO

Storage:-20C 2 years

Biologieal

Reference

1. HER2-targeted therapy in breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors. Dorte Lisbet Nielsen, Michael Andersson, and Claus Kamby. Cancer Treatment Reviews Volume 35, Issue

2, April 2009, Pages 121-136 2. HER-2-directed, small-molecule antagonists. Arkin, M., Moasser, M.M. Current Opinion in Investigational Drugs 2008 9 (12), pp. 1264-1276 3. Second-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer. Lecia V. Sequist. The Oncologist, Vol. 12, No.